Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6702 USD | +7.28% | -17.88% | +23.36% |
Mar. 22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
Mar. 14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
Financials (USD)
Sales 2024 * | 36.94M | Sales 2025 * | 64.14M | Capitalization | 136M |
---|---|---|---|---|---|
Net income 2024 * | -109M | Net income 2025 * | -82M | EV / Sales 2024 * | 4.8 x |
Net Debt 2024 * | 40.79M | Net Debt 2025 * | 129M | EV / Sales 2025 * | 4.14 x |
P/E ratio 2024 * |
-1.34
x | P/E ratio 2025 * |
-2.18
x | Employees | 405 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.55% |
Latest transcript on Sangamo Therapeutics, Inc.
1 day | +7.28% | ||
1 week | -17.88% | ||
Current month | -42.22% | ||
1 month | -40.69% | ||
3 months | +24.80% | ||
6 months | +11.83% | ||
Current year | +23.36% |
Managers | Title | Age | Since |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 16-05-31 |
Director of Finance/CFO | 46 | 19-02-28 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 22-12-14 |
James Meyers
BRD | Director/Board Member | 58 | 19-11-21 |
H. Parker
CHM | Chairman | 68 | 14-06-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.66% | 2 M€ | -25.75% | ||
0.49% | 17 M€ | -0.46% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.6702 | +7.28% | 1,252,490 |
24-03-27 | 0.6247 | +3.53% | 2,650,625 |
24-03-26 | 0.6034 | -5.97% | 2,282,595 |
24-03-25 | 0.6417 | -8.72% | 2,855,904 |
24-03-22 | 0.703 | -27.55% | 6,598,653 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.36% | 127M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |